Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome

  1. Alonso, C.
  2. Satta, V.
  3. Hernández-Fisac, I.
  4. Fernández-Ruiz, J.
  5. Sagredo, O.
Aldizkaria:
Neuropharmacology

ISSN: 1873-7064,  0028-3908

Argitalpen urtea: 2023

Alea: 237

Mota: Artikulua

DOI: 10.1016/J.NEUROPHARM.2023.109602 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus